Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 4 | $24,978,318 |
Sells | 135 | $62,568,618 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
22 Dec 2022 17:43 | DAWN | Day One Biopharmaceuticals Inc | YORK CHARLES N II | COO, CFO and Secretary | 20 Dec 2022 | Sale | 10,000 | 20.065 | 200,650 | D |
13 Feb 2023 18:28 | DAWN | Day One Biopharmaceuticals Inc | BLACKMAN SAMUEL C. | Chief Medical Officer | 10 Feb 2023 | Sale | 10,000 | 20.0659 | 200,659 | D |
22 Nov 2022 18:46 | DAWN | Day One Biopharmaceuticals Inc | YORK CHARLES N II | COO, CFO and Secretary | 21 Nov 2022 | Sale | 9,700 | 20.7374 | 201,153 | D |
23 Jan 2023 18:00 | DAWN | Day One Biopharmaceuticals Inc | YORK CHARLES N II | COO, CFO and Secretary | 20 Jan 2023 | Sale | 10,000 | 22.7523 | 227,523 | D |
06 Sep 2022 19:49 | DAWN | Day One Biopharmaceuticals Inc | BENDER JEREMY | Chief Executive Officer | 01 Sep 2022 | Sale | 10,641 | 23.1514 | 246,354 | D |
06 Sep 2022 19:50 | DAWN | Day One Biopharmaceuticals Inc | BENDER JEREMY | Chief Executive Officer | 01 Sep 2022 | Sale | 10,641 | 23.1514 | 246,354 | D |
05 Aug 2022 17:19 | DAWN | Day One Biopharmaceuticals Inc | BENDER JEREMY | Chief Executive Officer | 04 Aug 2022 | Sale | 12,500 | 20.0017 | 250,021 | D |
08 Mar 2023 17:50 | DAWN | Day One Biopharmaceuticals Inc | BENDER JEREMY | Chief Executive Officer | 07 Mar 2023 | Sale | 12,500 | 20.0091 | 250,114 | D |
03 Nov 2022 17:30 | DAWN | Day One Biopharmaceuticals Inc | BENDER JEREMY | Chief Executive Officer | 01 Nov 2022 | Sale | 12,500 | 20.0284 | 250,355 | D |
05 Oct 2022 16:22 | DAWN | Day One Biopharmaceuticals Inc | BENDER JEREMY | Chief Executive Officer | 03 Oct 2022 | Sale | 12,500 | 20.0517 | 250,646 | D |
22 Nov 2022 18:43 | DAWN | Day One Biopharmaceuticals Inc | BENDER JEREMY | Chief Executive Officer | 21 Nov 2022 | Sale | 12,100 | 20.7378 | 250,927 | D |
22 Dec 2022 17:50 | DAWN | Day One Biopharmaceuticals Inc | BENDER JEREMY | Chief Executive Officer | 21 Dec 2022 | Sale | 12,500 | 20.3175 | 253,969 | D |
24 Jan 2023 17:11 | DAWN | Day One Biopharmaceuticals Inc | BENDER JEREMY | Chief Executive Officer | 23 Jan 2023 | Sale | 12,500 | 21.999 | 274,988 | D |
28 Feb 2024 19:55 | DAWN | Day One Biopharmaceuticals Inc | BLACKMAN SAMUEL C. | HEAD OF R&D | 27 Feb 2024 | Sale | 20,000 | 16.1083 | 322,166 | D |
04 Jan 2023 17:51 | DAWN | Day One Biopharmaceuticals Inc | GRANT JULIE PAPANEK | Director | 03 Jan 2023 | Sale | 17,390 | 20.355 | 353,973 | I |
12 Jun 2024 16:29 | DAWN | Day One Biopharmaceuticals Inc | BLACKMAN SAMUEL C. | HEAD OF R&D | 10 Jun 2024 | Sale | 30,000 | 12.6196 | 378,588 | D |
13 Mar 2024 16:24 | DAWN | Day One Biopharmaceuticals Inc | BLACKMAN SAMUEL C. | HEAD OF R&D | 11 Mar 2024 | Sale | 30,000 | 15.2438 | 457,314 | D |
03 Mar 2023 17:48 | DAWN | Day One Biopharmaceuticals Inc | GRANT JULIE PAPANEK | Director | 01 Mar 2023 | Sale | 25,000 | 18.6121 | 465,303 | I |
03 Feb 2023 16:48 | DAWN | Day One Biopharmaceuticals Inc | GRANT JULIE PAPANEK | Director | 01 Feb 2023 | Sale | 23,894 | 21.2106 | 506,806 | I |
03 May 2024 18:44 | DAWN | Day One Biopharmaceuticals Inc | YORK CHARLES N II | COO, CFO AND SECRETARY | 01 May 2024 | Sale | 52,183 | 17.887 | 933,397 | D |
15 Sep 2022 19:53 | DAWN | Day One Biopharmaceuticals Inc | GRANT JULIE PAPANEK | Director | 15 Sep 2022 | Sale | 47,967 | 22.79 | 1,093,168 | I |
15 Sep 2022 19:48 | DAWN | Day One Biopharmaceuticals Inc | CANAAN XI L.P. | 10% | 15 Sep 2022 | Sale | 47,967 | 22.79 | 1,093,168 | D |
20 Oct 2023 16:02 | DAWN | Day One Biopharmaceuticals Inc | AI DAY1 LLC | 10% | 20 Oct 2023 | Purchase | 111,387 | 9.9734 | 1,110,907 | D |
03 May 2024 18:48 | DAWN | Day One Biopharmaceuticals Inc | BENDER JEREMY | CHIEF EXECUTIVE OFFICER | 01 May 2024 | Sale | 70,051 | 17.8753 | 1,252,183 | D |
20 Sep 2022 18:05 | DAWN | Day One Biopharmaceuticals Inc | GRANT JULIE PAPANEK | Director | 19 Sep 2022 | Sale | 76,725 | 20.57 | 1,578,233 | I |
20 Sep 2022 17:47 | DAWN | Day One Biopharmaceuticals Inc | CANAAN XI L.P. | 10% | 19 Sep 2022 | Sale | 76,725 | 20.57 | 1,578,233 | D |
15 Sep 2022 19:53 | DAWN | Day One Biopharmaceuticals Inc | GRANT JULIE PAPANEK | Director | 13 Sep 2022 | Sale | 86,644 | 24.39 | 2,113,247 | I |
15 Sep 2022 19:48 | DAWN | Day One Biopharmaceuticals Inc | CANAAN XI L.P. | 10% | 13 Sep 2022 | Sale | 86,644 | 24.39 | 2,113,247 | D |
20 Sep 2022 18:05 | DAWN | Day One Biopharmaceuticals Inc | GRANT JULIE PAPANEK | Director | 16 Sep 2022 | Sale | 111,585 | 21.53 | 2,402,425 | I |
20 Sep 2022 17:47 | DAWN | Day One Biopharmaceuticals Inc | CANAAN XI L.P. | 10% | 16 Sep 2022 | Sale | 111,585 | 21.53 | 2,402,425 | D |
15 Sep 2022 19:53 | DAWN | Day One Biopharmaceuticals Inc | GRANT JULIE PAPANEK | Director | 14 Sep 2022 | Sale | 105,727 | 23.68 | 2,503,615 | I |
15 Sep 2022 19:48 | DAWN | Day One Biopharmaceuticals Inc | CANAAN XI L.P. | 10% | 14 Sep 2022 | Sale | 105,727 | 23.68 | 2,503,615 | D |
20 Sep 2022 18:05 | DAWN | Day One Biopharmaceuticals Inc | GRANT JULIE PAPANEK | Director | 20 Sep 2022 | Sale | 146,404 | 19.5 | 2,854,878 | I |
20 Sep 2022 17:47 | DAWN | Day One Biopharmaceuticals Inc | CANAAN XI L.P. | 10% | 20 Sep 2022 | Sale | 146,404 | 19.5 | 2,854,878 | D |
20 Oct 2023 16:02 | DAWN | Day One Biopharmaceuticals Inc | AI DAY1 LLC | 10% | 19 Oct 2023 | Purchase | 384,400 | 10.0608 | 3,867,372 | D |
12 Jun 2023 16:03 | DAWN | Day One Biopharmaceuticals Inc | AI DAY1 LLC | 10% | 09 Jun 2023 | Purchase | 769,230 | 13 | 9,999,990 | D |
20 Oct 2023 16:02 | DAWN | Day One Biopharmaceuticals Inc | AI DAY1 LLC | 10% | 18 Oct 2023 | Purchase | 979,667 | 10.2076 | 10,000,049 | D |
22 Sep 2022 16:00 | DAWN | Day One Biopharmaceuticals Inc | GRANT JULIE PAPANEK | Director | 21 Sep 2022 | Sale | 607,497 | 18.54 | 11,262,994 | I |
22 Sep 2022 16:00 | DAWN | Day One Biopharmaceuticals Inc | CANAAN XI L.P. | 10% | 21 Sep 2022 | Sale | 607,497 | 18.54 | 11,262,994 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)